Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7890016rdf:typepubmed:Citationlld:pubmed
pubmed-article:7890016lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0038435lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0600251lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0010132lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0205178lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C2754073lld:lifeskim
pubmed-article:7890016lifeskim:mentionsumls-concept:C0205373lld:lifeskim
pubmed-article:7890016pubmed:issue11lld:pubmed
pubmed-article:7890016pubmed:dateCreated1995-4-14lld:pubmed
pubmed-article:7890016pubmed:abstractTextAcute stress results in activation of the hypothalamic-pituitary-adrenal (HPA) axis. ACTH and cortisol secretion is stimulated by corticotropin-releasing hormone (CRH). It has also been shown that activation of the HPA axis during stress is accompanied by changes in the immune response. However, little is known about the influence of acute stress on the release of cytokines such as interleukin-1 (IL-1) or interleukin-2 (IL-2). In this study, we determined serum IL-1 alpha and IL-2 levels in 19 patients undergoing the acute stress of angioplasty for coronary artery disease. A second protocol was devised to determine serum IL-1 alpha and IL-2 concentrations as well as lymphocyte subpopulations in 10 normal volunteers receiving 1 microgram kg-1 human CRH intravenously. Finally, IL-1 alpha concentrations were measured in CRH-incubated mononuclear cell (MNC) and monocyte cultures. In response to the stress of angioplasty, ACTH and cortisol as well as IL-1 alpha and IL-2 concentrations were clearly above baseline levels (IL-1 alpha, mean +/- SEM, baseline: 1.39 +/- 0.34 ng ml-1, after angioplasty: 2.64 +/- 0.73 ng ml-1, P < 0.05; IL-2, baseline: 1.2 +/- 0.13 ng ml-1, after angioplasty: 2.8 +/- 1.14 ng ml, P < 0.05). A similar pattern was obtained in normal subjects in response to CRH (Il-1 alpha, baseline: 0.8 +/- 0.2 ng ml-1, after angioplasty: 3.7 +/- 1.4 ng ml-1, P < 0.05; IL-2, baseline: 1.9 +/- 0.4 ng ml-1, after angioplasty: 5.4 +/- 2.2 ng ml-1, P < 0.02).(ABSTRACT TRUNCATED AT 250 WORDS)lld:pubmed
pubmed-article:7890016pubmed:languageenglld:pubmed
pubmed-article:7890016pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:citationSubsetIMlld:pubmed
pubmed-article:7890016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7890016pubmed:statusMEDLINElld:pubmed
pubmed-article:7890016pubmed:monthNovlld:pubmed
pubmed-article:7890016pubmed:issn0014-2972lld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:HerrmannGGlld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:BartlFFlld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:SchulteH MHMlld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:BambergerC...lld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:BambergerA...lld:pubmed
pubmed-article:7890016pubmed:authorpubmed-author:ElsenHHlld:pubmed
pubmed-article:7890016pubmed:issnTypePrintlld:pubmed
pubmed-article:7890016pubmed:volume24lld:pubmed
pubmed-article:7890016pubmed:ownerNLMlld:pubmed
pubmed-article:7890016pubmed:authorsCompleteYlld:pubmed
pubmed-article:7890016pubmed:pagination773-7lld:pubmed
pubmed-article:7890016pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:meshHeadingpubmed-meshheading:7890016-...lld:pubmed
pubmed-article:7890016pubmed:year1994lld:pubmed
pubmed-article:7890016pubmed:articleTitleSystemic interleukin-1 alpha and interleukin-2 secretion in response to acute stress and to corticotropin-releasing hormone in humans.lld:pubmed
pubmed-article:7890016pubmed:affiliationInstitute for Hormone and Fertility Research, University Hamburg, Germany.lld:pubmed
pubmed-article:7890016pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7890016lld:pubmed